MYCN and neuroblastoma: Recent study has regrouped NB into four distinct epigenetic subtypes based on the super-enhancer landscape and MYCN amplification status: MYCN-amplified high-risk, MYCN non-amplified high-risk, MYCN non-amplified low-risk, and mesenchymal-type (MES).